Speaker illustration

Doctor Agata Tyminska

Medical University of Warsaw, Warsaw (Poland)

Member of:

European Society of Cardiology

Association of galectin-3 and soluble ST2, and their changes, with echocardiographic parameters and development of heart failure after ST-segment elevation myocardial infarction.

Event: EuroEcho 2019

Topic: Systolic and Diastolic Function

Session: Echocardiography: Systolic and Diastolic Function


Carcinoid heart disease

Event: EuroEcho 2019

Topic: Valvular Heart Disease

Session: Echocardiography: Valve Disease


Influence of galectin-3 and soluble ST-2 on risk of death and heart failure hospitalization in patients after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention

Event: Heart Failure 2019

Topic: Biomarkers

Session: Chronic Heart Failure – Diagnostic Methods


Ischemic versus dilated cardiomyopathy - differences in clinical characteristics and prognosis depending on heart failure etiology.

Event: ESC Congress 2017

Topic: Prognosis

Session: Comorbidities in heart failure


Heart failure with Mid-Range ejection fraction - clinical characteristics and in-hospital outcomes. Insights into novel enigma based on the results from the ESC-HF Registries.

Event: ESC Congress 2017

Topic: Heart failure, other

Session: Acute heart failure (AHF)


Differences between randomized controlled clinical trials and real-world atrial fibrillation patients treated with oral anticoagulants - do we treat the same patients? Results from the CRAFT study

Event: ESC Congress 2017

Topic: Atrial fibrillation (AF)

Session: Stroke prevention


ESC 365 is supported by

logo Novo Nordisk
logo Bristol Myers Squibb